BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34296285)

  • 21. miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3.
    Qiu Z; Wang X; Shi Y; Da M
    Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(10):997-1007. PubMed ID: 31518383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway.
    Wang L; Wang L; Zhang H; Lu J; Zhang Z; Wu H; Liang Z
    Oncol Rep; 2020 May; 43(5):1558-1568. PubMed ID: 32323797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
    Han Q; Li J; Xiong J; Song Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer.
    Guo ST; Jiang CC; Wang GP; Li YP; Wang CY; Guo XY; Yang RH; Feng Y; Wang FH; Tseng HY; Thorne RF; Jin L; Zhang XD
    Oncogene; 2013 Apr; 32(15):1910-20. PubMed ID: 22710713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer.
    Long M; Zhan M; Xu S; Yang R; Chen W; Zhang S; Shi Y; He Q; Mohan M; Liu Q; Wang J
    Mol Cancer; 2017 Oct; 16(1):167. PubMed ID: 29078789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway.
    Zhou B; Guo W; Sun C; Zhang B; Zheng F
    Cell Death Dis; 2018 Jun; 9(6):706. PubMed ID: 29899418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.
    Li Z; Pan W; Shen Y; Chen Z; Zhang L; Zhang Y; Luo Q; Ying X
    Cell Cycle; 2018; 17(10):1212-1219. PubMed ID: 29886785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway.
    Wu SZ; Xu HC; Wu XL; Liu P; Shi YC; Pang P; Deng L; Zhou GX; Chen XY
    Phytomedicine; 2019 Jun; 59():152895. PubMed ID: 30913453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway.
    Li M; Guo H; Wang Q; Chen K; Marko K; Tian X; Yang Y
    Cancer Lett; 2020 Oct; 490():20-30. PubMed ID: 32585413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-4269 suppresses the tumorigenesis and development of pancreatic cancer by targeting ZEB1/OTX1 pathway.
    Sui X; Sui Z
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32484209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
    Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
    [No Abstract]   [Full Text] [Related]  

  • 32. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
    Xu DF; Wang LS; Zhou JH
    Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG.
    An N; Zheng B
    Technol Cancer Res Treat; 2020; 19():1533033819898729. PubMed ID: 32301392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
    Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
    Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
    [No Abstract]   [Full Text] [Related]  

  • 35. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a.
    Chen B; Li Q; Zhou Y; Wang X; Zhang Q; Wang Y; Zhuang H; Jiang X; Xiong W
    Cell Cycle; 2018; 17(16):1949-1966. PubMed ID: 30300116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis.
    Yao J; Zhang C; Chen Y; Gao S
    Life Sci; 2019 Dec; 239():116871. PubMed ID: 31521692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway.
    Jiang W; Zhao S; Jiang X; Zhang E; Hu G; Hu B; Zheng P; Xiao J; Lu Z; Lu Y; Ni J; Chen C; Wang X; Yang L; Wan R
    Cancer Lett; 2016 Feb; 371(2):314-25. PubMed ID: 26683776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1.
    Yuan L; Zhou C; Lu Y; Hong M; Zhang Z; Zhang Z; Chang Y; Zhang C; Li X
    Cancer Lett; 2015 Apr; 359(1):136-47. PubMed ID: 25592039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.